Ascendis Pharma Investigational Site

Montreal H4A 3J1

0 studies enrolling now · 2 studies all time

What they study most

2L+ Cervical Cancer, Achondroplasia, Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoadjuvant Melanoma, Neoadjuvant Non-Small Cell Lung Cancer, Platinum-resistant Ovarian Cancer, Post Anti-PD-(L)1 Non-Small Cell Lung Cancer, Post Anti-PD-(L)1 Small Cell Lung Cancer, Post Anti-PD-1 Melanoma, Second or Third Line (2L/3L) Cervical Cancer

Studies at this site

• A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia — Completed
• A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies — Running, not enrolling